O Pedersen-Bjergaard

441 total citations
17 papers, 266 citations indexed

About

O Pedersen-Bjergaard is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Complementary and alternative medicine. According to data from OpenAlex, O Pedersen-Bjergaard has authored 17 papers receiving a total of 266 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 2 papers in Surgery and 2 papers in Complementary and alternative medicine. Recurrent topics in O Pedersen-Bjergaard's work include Cardiac electrophysiology and arrhythmias (7 papers), Heart Failure Treatment and Management (3 papers) and Cardiac pacing and defibrillation studies (2 papers). O Pedersen-Bjergaard is often cited by papers focused on Cardiac electrophysiology and arrhythmias (7 papers), Heart Failure Treatment and Management (3 papers) and Cardiac pacing and defibrillation studies (2 papers). O Pedersen-Bjergaard collaborates with scholars based in Denmark. O Pedersen-Bjergaard's co-authors include Flemming Pedersen, J Frederiksen, Kresten Mellemgaard, B Sigurd, L Hagerup, Leif Spange Mortensen, J. F. Hansen, Jørgen Fischer Hansen, Verner Rasmussen and H Oxhøj and has published in prestigious journals such as The Lancet, The American Journal of Cardiology and Heart.

In The Last Decade

O Pedersen-Bjergaard

17 papers receiving 220 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O Pedersen-Bjergaard Denmark 6 219 61 33 20 19 17 266
H Saetre Sweden 8 234 1.1× 59 1.0× 18 0.5× 18 0.9× 22 1.2× 11 283
Catherine Cantillon United States 7 566 2.6× 36 0.6× 43 1.3× 23 1.1× 40 2.1× 8 638
S Scardi Italy 10 345 1.6× 62 1.0× 45 1.4× 13 0.7× 22 1.2× 69 423
Andreas Sjögren Sweden 7 317 1.4× 117 1.9× 84 2.5× 8 0.4× 14 0.7× 10 397
James L. Whittle United States 10 312 1.4× 177 2.9× 43 1.3× 7 0.3× 29 1.5× 15 390
R. van der Does Germany 11 320 1.5× 61 1.0× 73 2.2× 6 0.3× 25 1.3× 22 443
Shimon Braun Israel 9 219 1.0× 28 0.5× 24 0.7× 6 0.3× 50 2.6× 12 276
N. B. Karatzas United Kingdom 10 279 1.3× 36 0.6× 77 2.3× 10 0.5× 19 1.0× 17 379
Henry S. Sawin United States 8 183 0.8× 104 1.7× 68 2.1× 9 0.5× 13 0.7× 13 245
Kola Danisa United States 7 239 1.1× 45 0.7× 34 1.0× 7 0.3× 19 1.0× 8 317

Countries citing papers authored by O Pedersen-Bjergaard

Since Specialization
Citations

This map shows the geographic impact of O Pedersen-Bjergaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O Pedersen-Bjergaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O Pedersen-Bjergaard more than expected).

Fields of papers citing papers by O Pedersen-Bjergaard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O Pedersen-Bjergaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O Pedersen-Bjergaard. The network helps show where O Pedersen-Bjergaard may publish in the future.

Co-authorship network of co-authors of O Pedersen-Bjergaard

This figure shows the co-authorship network connecting the top 25 collaborators of O Pedersen-Bjergaard. A scholar is included among the top collaborators of O Pedersen-Bjergaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O Pedersen-Bjergaard. O Pedersen-Bjergaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Rasmussen, Verner, Jørgen Fischer Hansen, L Hagerup, et al.. (1998). Prognostic implications of ventricular ectopy one week, one month, and sixteen months after an acute myocardial infarction. Clinical Cardiology. 21(12). 905–911. 11 indexed citations
2.
Hansen, J. F., L Hagerup, B Sigurd, et al.. (1997). Cardiac Event Rates After Acute Myocardial Infarction in Patients Treated With Verapamil and Trandolapril Versus Trandolapril Alone. The American Journal of Cardiology. 79(6). 738–741. 62 indexed citations
3.
Hansen, Jørgen Fischer, L Hagerup, B Sigurd, et al.. (1997). Treatment with verapamil and trandolapril in patients with congestive heart failure and myocardial infarction. Journal of Hypertension. 15(2). S119–S122. 1 indexed citations
4.
Vaage‐Nilsen, Merete, Verner Rasmussen, L Hagerup, et al.. (1994). Effect of verapamil on arrhythmias and heart rate during 16 months following an acute myocardial infarction. Cardiovascular Drugs and Therapy. 8(1). 147–151. 6 indexed citations
5.
Pedersen-Bjergaard, O, et al.. (1986). [Disopyramide and lignocaine in the treatment of ventricular arrhythmia in patients with acute ischemic heart disease].. PubMed. 148(22). 1349–51. 1 indexed citations
6.
Frederiksen, J, et al.. (1984). III The Effect of Long‐Term Intervention with Alprenolol on Mortality in Definite or Suspected Myocardial Infarction. Acta Medica Scandinavica. 215(S680). 18–26. 3 indexed citations
7.
Frederiksen, J, et al.. (1984). II Study Design, Patient Characteristics and Conduct of the Study. Acta Medica Scandinavica. 215(S680). 8–17. 1 indexed citations
8.
Frederiksen, J, et al.. (1984). Effect of acute and long-term beta-adrenergic blockade with alprenolol in definite or suspected myocardial infarction. Study design, patient characteristics and conduct of the study.. PubMed. 680. 8–17. 4 indexed citations
9.
Frederiksen, J, et al.. (1981). Limitation of myocardial infarct size in patients less than 66 years treated with alprenolol.. Heart. 45(5). 583–588. 33 indexed citations
10.
Oxhøj, H, et al.. (1980). [Exercise test and exercise ECG in the diagnosis and treatment of ischemic heart disease].. PubMed. 142(27). 1743–9. 10 indexed citations
11.
Pedersen-Bjergaard, O, et al.. (1980). ST-junction and ST-segment changes and coronary artery disease.. PubMed. 27(3). 142–7. 1 indexed citations
12.
Frederiksen, J, et al.. (1979). EFFECT OF ALPRENOLOL ON MORTALITY AMONG PATIENTS WITH DEFINITE OR SUSPECTED ACUTE MYOCARDIAL INFARCTION. The Lancet. 314(8148). 865–868. 119 indexed citations
13.
Frederiksen, J, et al.. (1979). [Effect of alprenolol on the extent myocardial infarction assessed by serial determination of serum creatine kinase].. PubMed. 141(45). 3089–91. 2 indexed citations
14.
Hansen, Jørgen Fischer, O Pedersen-Bjergaard, Poul Stage, & F Efsen. (1975). IDIOPATHIC HYPERTROPHIC SUBAORTIC STENOSIS. Acta Medica Scandinavica. 197(1-6). 249–254. 3 indexed citations
15.
Pedersen-Bjergaard, O, et al.. (1974). Hand Blood Flow and Cardiac Functional Response to Severe Exercise in Normal Subjects and Patients with Valvular Heart Disease. Scandinavian Journal of Clinical and Laboratory Investigation. 34(2). 123–131. 1 indexed citations
16.
Tønnesen, K. H., et al.. (1974). Hand Blood Flow and Cardiac Functional Response to Severe Exercise in Normal Subjects and Patients with Valvular Heart Disease. Scandinavian Journal of Clinical and Laboratory Investigation. 34(2). 123–131. 3 indexed citations
17.
Pedersen-Bjergaard, O, et al.. (1973). The effect of physical training after myocardial infarction.. PubMed. 5(3). 105–10. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026